MedPath

tDCS and Speech Therapy to Improve Aphasia

Not Applicable
Conditions
Speech Therapy
Aphasia, Global
Stroke
Transcranial Direct Current Stimulation
Interventions
Procedure: tDCS + speech therapy
Registration Number
NCT02395874
Lead Sponsor
Medical Park AG
Brief Summary

To study the effect of combined tDCS plus speech therapy compared to sham-tDCS plus speech therapy in subacute stroke patients suffering from moderate or severe aphasia. The patients will be randomized by a computer-generated lot. Assessment will be performed at study onset, after six weeks at the end of the specific intervention and 4 months after stroke onset for follow-up.

Detailed Description

Approximately 25% of all patients after stroke suffer from aphasia. The aphasia could be so severe, that the patient cannot produce any words at all, and so the communication ability is rather poor. In that case speech therapy is the most common therapy, but the functional outcome for the patient is often not sufficiently. The transcranial direct current stimulation (tDCS) might improve the outcome of speech therapy in patients with severe aphasia. The patients will be randomized either to verum stimulation (group A) or sham stimulation (group B). In group A they will receive every workday for 6 weeks 20min of tDCS with 2 mA in combination with a 30 min speech therapy. In group B they will receive every workday for 6 weeks 20min of tDCS with 0 mA in combination with a 30 min speech therapy. The anodal electrode will be placed in case of a total anterior circulation stroke on the homologous speech area on the right hemisphere and in case of a partial anterior circulation stroke perilesional on the left hemisphere. The cathode will be positioned contralateral.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
96
Inclusion Criteria
  • first time stroke (ischemic or hemorrhagic), either with a total or partial anterior circulation stroke according to the Bamford classification
  • stroke interval 10-45 days
  • moderate or severe aphasia, i.e. Goodglass-Kaplan-Communication-Scale (GKS, 0,1 or 2)
  • native speaker - german
  • age 18-90
Exclusion Criteria
  • other neurological diseases affecting the CNS
  • known history of epileptic fits, except for an immediate fit
  • signs in the EEG of increased cortical excitability
  • patients with hemicraniectomy
  • fluent aphasia, i.e. GKS 3,4 or 5
  • speech apraxia
  • reduced sensibility of the scalp
  • previously radiated scalp
  • metallic parts or implants in the brain
  • participation in other interventional studies

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
sham-tDCStDCS + speech therapysham-tDCS + speech therapy
verum-tDCStDCS + speech therapyverum-tDCS+ speech therapy
Primary Outcome Measures
NameTimeMethod
Goodglass-Kaplan communication scale (GKS, 0-5)10-15 min

the GKS is an ordinal scale, which assesses the communication ability of the patient from 0 to 5.

Aphasia Check-list (ACL, 0-148)30-45 min

a german tool to assess language (analogous to the Aachener Aphasie Test). it measures a) colour-figure test, b) word generation and c) single speech domains

Secondary Outcome Measures
NameTimeMethod
Aphasic depression rating scale (ADRS, 0-32)5 min

rates the depression in patients with aphasia

Barthel-Index (BI,0-100)5min

evaluates the activities of daily living in patients suffering from stroke

Alterskonzentrationstest (AKT, 0-35)5 min

assesses the concentration and vigilance of elderly people with stroke

Rivermead Motor Assessment - Arm (RMA, 0-15)5-10 min

assesses the motor control of the upper extremity in patients with stroke

Trial Locations

Locations (1)

Medical Park Berlin Humboldtmuehle

🇩🇪

Berlin, Germany

© Copyright 2025. All Rights Reserved by MedPath